M. Dillingh

Topical ionic contra‐viral therapy comprised of digoxin and furosemide as a potential novel treatment approach for common warts

J. Bouwes Bavinck, R. Genders, M. D. de Koning, 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

Clinical Evaluation of Humira® Biosimilar ONS-3010 in Healthy Volunteers: Focus on Pharmacokinetics and Pharmacodynamics

M. Moerland, J. Burggraaf, J. Reijers, 2016, Front. Immunol..

Characterization of inflammation and immune cell modulation induced by low-dose LPS administration to healthy volunteers

E. Stroes, M. Moerland, E. Kemper, 2014, Journal of Inflammation.

Recombinant human serum amyloid P in healthy volunteers and patients with pulmonary fibrosis.

H. Hoogsteden, M. Wijsenbeek, M. Moerland, 2013, Pulmonary pharmacology & therapeutics.

Recombinant human pentraxin-2 therapy in patients with idiopathic pulmonary fibrosis: safety, pharmacokinetics and exploratory efficacy

M. Wijsenbeek, M. Moerland, B. Bartholmai, 2016, European Respiratory Journal.

Safety, tolerability and pharmacokinetic characterisation of DACRA KBP-042 in healthy male subjects

M. Karsdal, C. Christiansen, K. Henriksen, 2021 .

Characterization of immune cell, endothelial, and renal responses upon experimental human endotoxemia.

E. Stroes, M. D. de Kam, M. Moerland, 2018, Journal of pharmacological and toxicological methods.

Recombinant human pentraxin-2 therapy in patients with idiopathic pulmonary fibrosis: safety, pharmacokinetics and exploratory efficacy

M. Wijsenbeek, M. Moerland, B. Bartholmai, 2016, European Respiratory Journal.

Topical ionic contra‐viral therapy comprised of digoxin and furosemide as a potential novel treatment approach for common warts

R. Genders, R. Rijneveld, G. Feiss, 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.